Integrative modeling of hemodynamic changes and perfusion impairment in coronary microvascular disease

Monika Colombo1,2, Palak Chaudhry1, Yvonne Oberholzer1

  • 1Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zürich, Switzerland.

Insights

Researchers developed a novel workflow combining in vitro and in silico methods to analyze coronary microvascular disease. This approach quantifies hemodynamic changes in the microvasculature, offering a new strategy for understanding this complex cardiac condition.

Area of Science:

  • Cardiovascular Research
  • Biomedical Engineering
  • Computational Fluid Dynamics

Background:

  • Coronary microvascular disease impairs cardiac perfusion and presents diagnostic/treatment challenges.
  • Alterations in local hemodynamics characterize this pathology, making it a significant clinical problem.
  • Current understanding of disease onset and progression remains limited.

Purpose of the Study:

  • To propose a novel, noninvasive strategy for quantifying in vivo hemodynamic changes in the microvasculature.
  • To develop a workflow for analyzing hemodynamic alterations in coronary microvascular disease.
  • To establish a platform for multiscale analysis of multifactorial events in this condition.

Main Methods:

  • Developed a hybrid additive manufacturing process for biocompatible, polytetrafluoroethylene microfluidic devices.
  • Utilized computational fluid dynamics (CFD) to simulate hemodynamic changes.
  • Combined in vitro microfluidic models with in silico simulations for analysis.

Main Results:

  • Successfully fabricated microfluidic networks with circular cross-sections.
  • Demonstrated the simulation of varying degrees of cardiac perfusion impairment.
  • Validated the workflow as a robust platform for multiscale analysis.

Conclusions:

  • The developed workflow provides a robust platform for analyzing coronary microvascular disease.
  • This approach enables the multiscale investigation of multifactorial events.
  • Offers a new strategy for understanding and potentially treating microvascular dysfunction.